Immunoprofiling of mismatch repair-deficient (MMRd) endometrial cancer (EC) patients (pts): Immune checkpoint inhibitor (ICI)-responders (R) versus non-responders (NR)-MedSci.cn

Immunoprofiling of mismatch repair-deficient (MMRd) endometrial cancer (EC) patients (pts): Immune checkpoint inhibitor (ICI)-responders (R) versus non-responders (NR)

Bejar, JFG; Galende, EY; Genestie, C; Scoazec, JY; Edmond, E; Le Formal, A; Blanc-Durand, F; Michels, J; Kfoury, M; Morice, P; Pautier, P; Colomba, E; Leary, A

ANNALS OF ONCOLOGY, 2022; 33 (7): S800

科室
- - 订阅+
  - 更多科室
工具
服务